{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:19:04Z","timestamp":1792113544258,"version":"4.4.0"},"reference-count":112,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Antibiotics have made it possible to treat bacterial infections such as meningitis and bacteraemia that, prior to their introduction, were untreatable and consequently fatal. Unfortunately, in recent decades overuse and misuse of antibiotics as well as social and economic factors have accelerated the spread of antibiotic-resistant bacteria, making drug treatment ineffective. Currently, at least 700,000 people worldwide die each year due to antimicrobial resistance (AMR). Without new and better treatments, the World Health Organization (WHO) predicts that this number could rise to 10 million by 2050, highlighting a health concern not of secondary importance. In February 2017, in light of increasing antibiotic resistance, the WHO published a list of pathogens that includes the pathogens designated by the acronym ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) to which were given the highest \u201cpriority status\u201d since they represent the great threat to humans. Understanding the resistance mechanisms of these bacteria is a key step in the development of new antimicrobial drugs to tackle drug-resistant bacteria. In this review, both the mode of action and the mechanisms of resistance of commonly used antimicrobials will be examined. It also discusses the current state of AMR in the most critical resistant bacteria as determined by the WHO\u2019s global priority pathogens list.<\/jats:p>","DOI":"10.3390\/pathogens10101310","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T06:38:41Z","timestamp":1634107121000},"page":"1310","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1258,"title":["Bacterial Antibiotic Resistance: The Most Critical Pathogens"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-3228","authenticated-orcid":false,"given":"Giuseppe","family":"Mancuso","sequence":"first","affiliation":[{"name":"Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Midiri","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Gerace","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, 98100 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Biondo","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"ref_1","first-page":"114","article-title":"Antimicrobial resistance induced by genetic changes","volume":"2","author":"Coculescu","year":"2009","journal-title":"J. Med. Life"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Collignon, P., and Beggs, J.J. (2019). Socioeconomic Enablers for Contagion: Factors Impelling the Antimicrobial Resistance Epidemic. Antibiotics, 8.","DOI":"10.3390\/antibiotics8030086"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3184\/003685002783238870","article-title":"Methicillin Resistance in Staphylococcus Aureus: Mechanisms and Modulation","volume":"85","author":"Stapleton","year":"2002","journal-title":"Sci. Prog."},{"key":"ref_4","first-page":"269","article-title":"Vancomycin Resistance in Staphylococcus aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: A rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_7","first-page":"181","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"Forde","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2475067","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., Jubeh, B., and Karaman, R. (2020). Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules, 25.","DOI":"10.3390\/molecules25061340"},{"key":"ref_10","unstructured":"WHO (2020, December 18). W.H.O. 10 Threats to Global Health in 2018. Available online: https:\/\/medium.com\/@who\/10-threats-to-global-health-in-2018-232daf0bbef32018."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Abdelaziz, S., Aboshanab, K., Yahia, I., Yassien, M., and Hassouna, N. (2021). Correlation between the Antibiotic Resistance Genes and Susceptibility to Antibiotics among the Carbapenem-Resistant Gram-Negative Pathogens. Antibiotics, 10.","DOI":"10.3390\/antibiotics10030255"},{"key":"ref_12","unstructured":"World Health Organization (2020, December 18). Ten Threats to Global Health in 2019. Available online: https:\/\/www.who.int\/emergencies\/ten-threats-to-global-health-in-2019."},{"key":"ref_13","unstructured":"ECDC (2020, December 18). Communicable Disease and Threats Report CDTR, Available online: www.ecdc.europa.e."},{"key":"ref_14","unstructured":"ECDC (2020, December 18). Biggest Threats and Data, Available online: https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf2019."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cepas, V., and Soto, S.M. (2020). Relationship between Virulence and Resistance among Gram-Negative Bacteria. Antibiotics, 9.","DOI":"10.3390\/antibiotics9100719"},{"key":"ref_16","first-page":"93","article-title":"Antibiotics Overuse and Bacterial Resistance","volume":"3","author":"Korzen","year":"2019","journal-title":"Ann. Microbiol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14737","DOI":"10.1038\/s41598-020-70517-w","article-title":"Antimicrobial resistance at the human\u2013animal interface in the Pastoralist Communities of Kasese District, South Western Uganda","volume":"10","author":"Iramiot","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1038\/s41598-019-46078-y","article-title":"Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse","volume":"9","author":"Malik","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fmicb.2018.00828","article-title":"The Genomic Basis of Intrinsic and Acquired Antibiotic Resistance in the Genus Serratia","volume":"9","author":"Vinuesa","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.envres.2018.11.040","article-title":"Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review","volume":"169","author":"Ben","year":"2019","journal-title":"Environ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10354-018-0676-5","article-title":"Control of hospital acquired infections and antimicrobial resistance in Europe: The way to go","volume":"169","author":"Friedrich","year":"2019","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3389\/fmicb.2019.01933","article-title":"Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Benk\u0151, R., Gajd\u00e1cs, M., Matuz, M., Bod\u00f3, G., L\u00e1z\u00e1r, A., Hajd\u00fa, E., Papfalvi, E., Hannauer, P., Erd\u00e9lyi, P., and Pet\u0151, Z. (2020). Prevalence and Antibiotic Resistance of ESKAPE Pathogens Isolated in the Emergency Department of a Tertiary Care Teaching Hospital in Hungary: A 5-Year Retrospective Survey. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090624"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: A guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Schroeder, M., Brooks, B.D., and Brooks, A.E. (2017). The Complex Relationship between Virulence and Antibiotic Resistance. Genes, 8.","DOI":"10.3390\/genes8010039"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2147\/IDR.S306688","article-title":"Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital","volume":"14","author":"Pandey","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","article-title":"Uncovering the mechanisms of Acinetobacter baumannii virulence","volume":"16","author":"Harding","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kyriakidis, I., Vasileiou, E., Pana, Z., and Tragiannidis, A. (2021). Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens, 10.","DOI":"10.3390\/pathogens10030373"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Vrancianu, C.O., Gheorghe, I., Czobor, I.B., and Chifiriuc, M.C. (2020). Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii. Microorganisms, 8.","DOI":"10.3390\/microorganisms8060935"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2174\/1389450116666151001105622","article-title":"B1-Metallo-\u03b2-Lactamases: Where Do We Stand?","volume":"17","author":"Mojica","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","article-title":"Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment","volume":"22","author":"Shaikh","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology","volume":"12","author":"Poirel","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Halat, D.H., and Moubareck, C.A. (2020). The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics, 9.","DOI":"10.3390\/antibiotics9040186"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1128\/AAC.48.4.1374-1378.2004","article-title":"Molecular Characterization of the Gene Encoding a New AmpC \u03b2-Lactamase in a Clinical Strain of Acinetobacter Genomic Species 3","volume":"48","author":"Beceiro","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/IDR.S228089","article-title":"Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance","volume":"13","author":"Abdi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Basatian-Tashkan, B., Niakan, M., Khaledi, M., Afkhami, H., Sameni, F., Bakhti, S., and Mirnejad, R. (2020). Antibiotic resistance assessment of Acinetobacter baumannii isolates from Tehran hospitals due to the presence of efflux pumps encoding genes (adeA and adeS genes) by molecular method. BMC Res. Notes, 13.","DOI":"10.1186\/s13104-020-05387-6"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e02190-18","DOI":"10.1128\/AAC.02190-18","article-title":"Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of Acinetobacter baumannii ATCC 17978","volume":"63","author":"Corral","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.nmni.2019.100549","article-title":"adeABC efflux gene in Acinetobacter baumannii","volume":"30","author":"Xu","year":"2019","journal-title":"New Microbes New Infect."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fmicb.2013.00121","article-title":"Rise and dissemination of aminoglycoside resistance: The aac(6\u2032)-Ib paradigm","volume":"4","author":"Ramirez","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"610109","DOI":"10.3389\/fmicb.2020.610109","article-title":"Impact of an Intervention to Control Imipenem-Resistant Acinetobacter baumannii and Its Resistance Mechanisms: An 8-Year Survey","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/IDR.S166750","article-title":"Insight into Acinetobacter baumannii: Pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities","volume":"11","author":"Asif","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.sjbs.2016.02.009","article-title":"Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features","volume":"25","author":"Almasaudi","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1128\/JB.00435-12","article-title":"OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii","volume":"194","author":"Sugawara","year":"2012","journal-title":"J. Bacteriol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fmicb.2020.00573","article-title":"Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme","volume":"11","author":"Kamoshida","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/IDR.S148185","article-title":"In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital","volume":"10","author":"Lertsrisatit","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-L\u00f3pez, R., Solano-G\u00e1lvez, S.G., Vignon-Whaley, J.J.J., Vaamonde, J.A.A., Alonzo, L.A.P., Res\u00e9ndiz, A.R., \u00c1lvarez, M.M., L\u00f3pez, E.N.V., Franyuti-Kelly, G., and \u00c1lvarez-Hern\u00e1ndez, D.A. (2020). Acinetobacter baumannii Resistance: A Real Challenge for Clinicians. Antibiotics, 9.","DOI":"10.3390\/antibiotics9040205"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/mdr.2016.0043","article-title":"Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram\u2013Negative Organisms?","volume":"23","author":"Shankar","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fpubh.2019.00151","article-title":"The \u201cOld\u201d and the \u201cNew\u201d Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How","volume":"7","author":"Karaiskos","year":"2019","journal-title":"Front. Public Health"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bagi\u0144ska, N., Cie\u015blik, M., G\u00f3rski, A., and Jo\u0144czyk-Matysiak, E. (2021). The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy. Antibiotics, 10.","DOI":"10.3390\/antibiotics10030281"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12098-020-03346-4","article-title":"Susceptibility Patterns of Multidrug-Resistant Acinetobacter baumannii","volume":"88","author":"Konca","year":"2021","journal-title":"Indian J. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1128\/AAC.01082-16","article-title":"In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates","volume":"60","author":"Nepka","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jurado-Mart\u00edn, I., Sainz-Mej\u00edas, M., and McClean, S. (2021). Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063128"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcimb.2017.00039","article-title":"Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence","volume":"7","author":"Moradali","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e01759-19","DOI":"10.1128\/AAC.01759-19","article-title":"Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence","volume":"64","author":"Recio","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_57","first-page":"1","article-title":"Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa","volume":"9","author":"Hwang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/AAC.00148-07","article-title":"Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with Hypermutation","volume":"51","author":"Henrichfreise","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"665759","DOI":"10.3389\/fcimb.2021.665759","article-title":"The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies","volume":"11","author":"Langendonk","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e02252-16","DOI":"10.1128\/AAC.02252-16","article-title":"Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States","volume":"61","author":"Sader","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2147\/IDR.S255292","article-title":"Distribution of Class B and Class A \u03b2-Lactamases in Clinical Strains of Pseudomonas aeruginosa: Comparison of Phenotypic Methods and High-Resolution Melting Analysis (HRMA) Assay","volume":"13","author":"Dehbashi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","article-title":"Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review","volume":"6","author":"Pachori","year":"2019","journal-title":"Genes Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1128\/AAC.00825-15","article-title":"Mutations in \u03b2-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins","volume":"59","author":"Berrazeg","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-76355-0","article-title":"Retention of antibiotic activity against resistant bacteria harbouring aminoglycoside-N-acetyltransferase enzyme by adjuvants: A combination of in-silico and in-vitro study","volume":"10","author":"Ahmed","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ontong, J.C., Ozioma, N.F., Voravuthikunchai, S.P., and Chusri, S. (2021). Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0244673"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Pungcharoenkijkul, S., Traipattanakul, J., Thunyaharn, S., and Santimaleeworagun, W. (2020). Antimicrobials as Single and Combination Therapy for Colistin-Resistant Pseudomonas aeruginosa at a University Hospital in Thailand. Antibiotics, 9.","DOI":"10.3390\/antibiotics9080475"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"930","DOI":"10.7754\/Clin.Lab.2020.200930","article-title":"Staphylococcus aureus, ESKAPE Bacteria Challenging Current Health Care and Community Settings: A Literature Review","volume":"67","author":"Tigabu","year":"2021","journal-title":"Clin. Lab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"638085","DOI":"10.3389\/fimmu.2021.638085","article-title":"Mechanisms of Antibiotic Failure During Staphylococcus aureus Osteomyelitis","volume":"12","author":"Gimza","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcimb.2020.00107","article-title":"Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus","volume":"10","author":"Guo","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic Resistance and the MRSA Problem","volume":"7","author":"Vestergaard","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1139\/cjm-2019-0309","article-title":"Renaissance of vancomycin: Approaches for breaking antibiotic resistance in multidrug-resistant bacteria","volume":"66","author":"Kleist","year":"2020","journal-title":"Can. J. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features","volume":"21","author":"Cong","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/AAC.00346-09","article-title":"VanA-Type Vancomycin-Resistant Staphylococcus aureus","volume":"53","author":"Courvalin","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_78","first-page":"93","article-title":"Vancomycin-Resistant Staphylococcus aureus: Formidable Threat or Silence before the Storm?","volume":"5","author":"Kest","year":"2019","journal-title":"Infect. Dis. Epidemiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: A systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1473-3099(14)70876-X","article-title":"A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: An observational cohort study","volume":"14","author":"Yaw","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Nicolas, I., Bordeau, V., Bondon, A., Baudy-Floc\u2019H, M., and Felden, B. (2019). Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000337"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkt374","article-title":"Oral antibiotic treatment of staphylococcal bone and joint infections in adults","volume":"69","author":"Kim","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.24171\/j.phrp.2019.10.1.06","article-title":"Analysis of Resistance to Macrolide\u2013Lincosamide\u2013Streptogramin B Among mecA-Positive Staphylococcus Aureus Isolates","volume":"10","author":"Khodabandeh","year":"2019","journal-title":"Osong Public Health Res. Perspect."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"FSO361","DOI":"10.2144\/fsoa-2020-0092","article-title":"Inducible clindamycin resistance and erm genes in Staphylococcus aureus in school children in Kathmandu, Nepal","volume":"7","author":"Timsina","year":"2021","journal-title":"Futur. Sci. OA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/426894","article-title":"Inducible Clindamycin Resistance in Staphylococci: Should Clinicians and Microbiologists be Concerned?","volume":"40","author":"Lewis","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JCM.42.4.1800-1802.2004","article-title":"Detection of Inducible Clindamycin Resistance of Staphylococci in Conjunction with Performance of Automated Broth Susceptibility Testing","volume":"42","author":"Jorgensen","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Caneiras, C., Lito, L., Melo-Cristino, J., and Duarte, A. (2019). Community- and Hospital-Acquired Klebsiella pneumoniae Urinary Tract Infections in Portugal: Virulence and Antibiotic Resistance. Microorganisms, 7.","DOI":"10.3390\/microorganisms7050138"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1556\/030.66.2019.006","article-title":"Antibiotic resistance, virulence and genetic diversity of Klebsiella pneumoniae in community- and hospital-acquired urinary tract infections in Iran","volume":"66","author":"Eghbalpoor","year":"2019","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e00071-20","DOI":"10.1128\/IAI.00071-20","article-title":"Animal Model to Study Klebsiella pneumoniae Gastrointestinal Colonization and Host-to-Host Transmission","volume":"88","author":"Young","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-019-0343-8","article-title":"Klebsiella pneumoniae: An increasing threat to public health","volume":"19","author":"Effah","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-020-0716-3","article-title":"Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology","volume":"22","author":"Lasko","year":"2020","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3855\/jidc.12267","article-title":"Factors associated with mortality in Infections caused by Carbapenem-resistant Enterobacteriaceae","volume":"14","author":"Gualtero","year":"2020","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fmicb.2019.00080","article-title":"Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options","volume":"10","author":"Sheu","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_95","first-page":"392","article-title":"Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment","volume":"6","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jgar.2021.04.008","article-title":"Clinical characteristics and outcome of bacteraemia caused by Enterobacter cloacae and Klebsiella aerogenes: More similarities than differences","volume":"25","author":"Lepe","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Reza, A., Sutton, J.M., and Rahman, K.M. (2019). Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria. Antibiotics, 8.","DOI":"10.20944\/preprints201910.0255.v1"},{"key":"ref_98","first-page":"37","article-title":"Antibiotic resistance in Enterobacter cloacae strains with derepressed\/partly derepressed\/inducible AmpC and extendedspectrum beta-lactamases in Zenica-Doboj Canton, Bosnia and Herzegovina","volume":"15","year":"2018","journal-title":"Medicinski Glasnik"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Di Franco, S., Alfieri, A., Pace, M., Sansone, P., Pota, V., Fittipaldi, C., Fiore, M., and Passavanti, M. (2021). Blood Stream Infections from MDR Bacteria. Life, 11.","DOI":"10.3390\/life11060575"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1038\/nmicrobiol.2016.53","article-title":"Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae","volume":"1","author":"Band","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e00058-18","DOI":"10.1128\/CMR.00058-18","article-title":"The Enterococcus: A Model of Adaptability to Its Environment","volume":"32","author":"Rice","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2147\/IDR.S206084","article-title":"Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: A systematic review and meta-analysis","volume":"12","author":"Shiadeh","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-021-21749-5","article-title":"Apparent nosocomial adaptation of Enterococcus faecalis predates the modern hospital era","volume":"12","author":"Top","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ramos, S., Silva, V., Dapkevicius, M., Igrejas, G., and Poeta, P. (2020). Enterococci, from Harmless Bacteria to a Pathogen. Microorganisms, 8.","DOI":"10.20944\/preprints202007.0393.v1"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1038\/s41598-020-61002-5","article-title":"Surveillance of Enterococcus spp. reveals distinct species and antimicrobial resistance diversity across a One-Health continuum","volume":"10","author":"Zaheer","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Jubeh, B., Breijyeh, Z., and Karaman, R. (2020). Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches. Molecules, 25.","DOI":"10.3390\/molecules25122888"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3389\/fmicb.2018.01175","article-title":"Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs with a High in Vitro Therapeutic Index","volume":"9","author":"Mishra","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-Resistant Enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Kim, M., Moon, D., Kim, S.-J., Mechesso, A., Song, H.-J., Kang, H., Choi, J.-H., Yoon, S.-S., and Lim, S.-K. (2021). Nationwide Surveillance on Antimicrobial Resistance Profiles of Enterococcus faecium and Enterococcus faecalis Isolated from Healthy Food Animals in South Korea, 2010 to 2019. Microorganisms, 9.","DOI":"10.3390\/microorganisms9050925"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","article-title":"Mechanisms and clinical relevance of bacterial heteroresistance","volume":"17","author":"Andersson","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijantimicag.2004.02.021","article-title":"Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus","volume":"24","author":"Metzler","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fmicb.2019.00042","article-title":"Variation in Mutant Prevention Concentrations","volume":"10","author":"Gianvecchio","year":"2019","journal-title":"Front. Microbiol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/10\/1310\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:12:15Z","timestamp":1760166735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/10\/1310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":112,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["pathogens10101310"],"URL":"https:\/\/doi.org\/10.3390\/pathogens10101310","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}